Travera announces publication of groundbreaking clinical data from their disruptive Rapid Therapy Selection (RTS) Test ™

A cutting-edge study titled "Cellular Mass Response to Therapy Correlates with Clinical Response for a Range of Malignancies" has been published in the Journal of Clinical Oncology Precision Medicine, shedding light on a promising and potentially disruptive approach to cancer therapy...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: TRI Source Type: news